Finance

Lists
4YX0:FRA
Rhelion Life Sciences Corp
€0.0030
0.00%
(0.00) 1D
Sep 3, 8:03:46 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4YX0...
Open
€0.00
High
€0.00
Low
€0.00
Mkt. cap
17.34M
Volume
0.00
52-wk high
€0.01
52-wk low
€0.00
Open
€0.00
High
€0.00
Low
€0.00
Mkt. cap
17.34M
Volume
0.00
52-wk high
€0.01
52-wk low
€0.00
About Rhelion Life Sciences Corp
CEO-
Employees-
Founded1982
HeadquartersToronto, Ontario, Canada
SectorFood
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
754.08K
1.26M
875.32K
186.07K
Cost of goods sold
426.79K
906.88K
416.75K
16.33K
Cost of revenue
426.79K
906.88K
416.75K
16.33K
Research and development expenses
2.87K
8.17K
6.50K
84.12K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.28M
1.20M
1.74M
1.33M
Operating expense
1.32M
1.56M
1.55M
1.61M
Total operating expenses
1.75M
2.46M
1.97M
1.63M
Operating income
-996.24K
-1.20M
-1.09M
-1.44M
Other non operating income
-
-
-
-
EBT including unusual items
-1.23M
-1.44M
-3.43M
-1.50M
EBT excluding unusual items
-942.74K
-1.16M
-1.06M
-1.44M
Income tax expense
-41.66K
-28.60K
-234.41K
-
Effective tax rate
3.38%
1.99%
6.83%
-
Other operating expenses
-
-
-
-
Net income
-1.17M
-1.38M
-2.53M
-1.87M
Net profit margin
-154.72%
-109.02%
-288.81%
-1,003.17%
Earnings per share
-
-
-
-
Interest and investment income
68.90K
52.32K
47.39K
44.36K
Interest expense
-15.39K
-12.70K
-11.50K
-11.03K
Net interest expenses
53.51K
39.62K
35.89K
33.32K
Depreciation and amortization charges
-
-
-
-
EBITDA
-920.66K
-1.13M
-1.03M
-1.34M
Gain or loss from assets sale
-
24.86K
1.30K
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps